Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03370393 · ClinicalTrials.gov registry record · NA

Prevention of Adolescent Risky Behaviors: Neural Markers of Intervention Effects

A NA study of Adolescent Behavior and Risk-Taking, sponsored by University of California, Irvine.

Completed
Registry status
NA
Development phase
146
Enrollment target
1
Study location

NCT03370393: Completed NA study of Adolescent Behavior and Risk-Taking, sponsored by University of California, Irvine.

NCT03370393 is a NA study of Adolescent Behavior and Risk-Taking that has completed, run by University of California, Irvine. The registered enrollment target is 146 participants, below the 327-participant average among 46 other Adolescent Behavior trials with a reported enrollment target (55% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03370393, a NA study of Adolescent Behavior and Risk-Taking, has completed, sponsored by University of California, Irvine.

COMPLETED
Registry status
NA
Development phase
146 participants
Enrollment target
1
Study location

Study Summary

Adolescence is a time of biological and behavioral changes that can lead to risky and dangerous behaviors, and African-American youth are highly vulnerable to the consequences of risky behavior, including HIV/AIDS and violence, leading to premature death. The investigators previously showed that an intervention program reduces HIV-risk vulnerability behaviors in many African-American youth. The investigators aim to measure how the program affects different regions of the brain in order to better prevent or reduce such risky behaviors among African-American youth.

Primary Outcome

Emotional regulation was assessed through parent and youth self-reported questionnaires using the Behavior Rating Inventory of Executive Function, Second Edition (BRIEF-2). T scores, normed for age and sex are available. T-score standardizes an individual's executive functioning difficulties relative to peers. For example, 50 is the population mean and a standard deviation of 10. Higher scores indicate more significant problems. Scores below 60 are within normal limits; 60-64: subclinical diffic

Interventions

  • BEHAVIORAL Pathways for African-Americans' Success (PAAS)

Study Locations (1)

California

  • University of California, Irvine - Irvine

Trial Details

FieldValue
Enrollment Target 146 participants
Start Date 2017-12-11
Est. Completion 2025-04-10
Phase NA
University of California, Irvine

368 total trials

What the finished NCT03370393 record still lists

NCT03370393 is an interventional study that assigns participants to a tested intervention. The registered 146 participants enrollment target is mid-sized for trials with a published cap, below the 327-participant average among 46 other Adolescent Behavior trials with a reported enrollment target (55% lower).

The record links to 2 conditions, with Adolescent Behavior appearing as the primary indexed condition, and to 1 intervention - of which Pathways for African-Americans' Success (PAAS) is the first listed.

NCT03370393 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT03370393 about?

NCT03370393 is a clinical study titled "Prevention of Adolescent Risky Behaviors: Neural Markers of Intervention Effects". Adolescence is a time of biological and behavioral changes that can lead to risky and dangerous behaviors, and African-American youth are highly vulnerable to the consequences of risky behavior, including HIV/AIDS and violence, leading to premature death. The investigators previously showed that an ...

What is the current status of trial NCT03370393?

This trial is currently completed. It is a NA study. The enrollment target is 146 participants. The study started on 2017-12-11. Estimated completion is 2025-04-10.

What conditions does trial NCT03370393 study?

This clinical trial studies the following conditions: Adolescent Behavior, Risk-Taking.

What interventions are being tested in trial NCT03370393?

The interventions under investigation include: Pathways for African-Americans' Success (PAAS) (BEHAVIORAL).

Who is sponsoring clinical trial NCT03370393?

This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03370393 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Adolescent Behavior

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03370393's enrollment target sits among peer trials

146 28th of 46 higher than 19 of 46 other Adolescent Behavior trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Adolescent Behavior trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03490929 · 146 participants · Phase 4

    CEUS for Blunt Abdominal Trauma in Children

  • NCT04755062 · 146 participants · NA

    A Culturally-relevant Micronutrient-dense Plant-rich (mNDPR) Dietary Intervention for Native Americans

  • NCT04867954 · 146 participants

    Development of 4D Flow MRI for Risk Stratification of Variceal Bleeding in Cirrhosis

  • NCT05051618 · 146 participants · NA

    Exercise Training for Managing Major Depressive Disorder in Multiple Sclerosis

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03370393, the US trial registry maintained by the National Library of Medicine. NCT03370393 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.